President Donald Trump faced sharp criticism after mocking an unnamed wealthy friend's experience with the weight-loss drug Ozempic while promoting his administration's healthcare agenda. Speaking at a White House roundtable on rural healthcare investment, Trump digressed into an anecdote about a 'very smart', 'very, very rich' and 'very powerful' friend who he said remained 'very fat' despite taking Ozempic, a medication widely used in the United States for weight management and diabetes care. The president said the friend purchased the drug for £971 ($1,300) per month in New York but only £65 ($87) in London, a disparity he used to underline his call for lower US prescription drug prices.
